Multifunctional Janus Nanoparticles Capable of Anchoring to the Cell Membrane and Serving as “Cellular Backpacks” for Advanced Theranostics — Min Hao (2025) | RDL Network
Multifunctional Janus Nanoparticles Capable of Anchoring to the Cell Membrane and Serving as “Cellular Backpacks” for Advanced Theranostics
Article 2025 en
Authors
MH
Min Hao
YC
Yidan Chen
JL
Johannes Leisen
Abstract
1 min read
A cell-based theranostic system can be fabricated by attaching nanomedicines to the surface of carrier cells, but it remains a challenge to achieve the attachment without involving endocytosis. Herein, we address this challenge by developing multifunctional Janus nanoparticles with orthogonal surface properties for the two opposite halves. When incubated with carrier cells, the hydrophobic half made of polystyrene readily inserts into the plasma membrane, whereas the hydrophilic SiO2 half grafted with poly(ethylene glycol) protrudes away from the cell surface. Additionally, the SiO2 half can be made with a cavity to hold theranostic agents and thus serves as a "backpack" for the carrier cell. By confining the theranostic agents in the SiO2 compartment and outside the carrier cell during the delivery process, their adverse impact on the cell is minimized. Upon release in an in vitro spheroid model, the agents quickly eradicate cancer cells. Moreover, the polystyrene half can be loaded with superparamagnetic nanoparticles to enhance magnetic resonance imaging contrast and enable magnetic manipulation, facilitating image-guided and target-directed treatments. By further optimizing the interactions between the multifunctional Janus nanoparticles and carrier cells, this system can be developed into a robust platform for cell-based theranostics.
Inês Ferreira-Faria, Satar Yousefiasl, Ana Macário‐Soares, Miguel Pereira‐Silva, Diana Peixoto, Hajra Zafar, Faisal Raza, Henrique Faneca, Francisco Veiga, Michael R Hamblin, Franklin R. Tay, Jianqing Gao, Esmaeel Sharifi, Pooyan Makvandi, Ana Cláudia Paiva‐Santos
Discussion(0)
No comments yet. Be the first to comment.